Nikesh Kotecha

Nikesh Kotecha, Ph.D., Co-Founder

Nikesh’s focus is on delivering computational and molecular technologies to the clinic, and he currently serves as Vice President of Informatics at the Parker Institute for Cancer Immunotherapy. The Cytobank project grew out of his work in Dr. Garry Nolan’s lab at Stanford University developing a diagnostic for juvenile myelomonocytic leukemia and on analysis methods for single-cell assays. Nikesh received his Ph.D. in Biomedical Informatics from Stanford University and his B.S. in Biomedical Engineering from Boston University. Nikesh’s past experiences include work at TIBCO Spotfire Inc. and Pfizer Inc. in multiple roles and departments including engineering, technical sales, and business development. Nikesh is also a consulting faculty member in the Computational and Systems Immunology program at Stanford University.

Bill Hyun

Bill Hyun, MS, Ph.D., Advisor

Bill Hyun is the Director of the Laboratory for Advanced Cytometry at the University of California, San Francisco (UCSF). He leverages over 25 years of translational and clinical research experience into founder, investor and advisor roles for several biotechnology companies and life science investment groups. At UCSF, he helped build the world’s largest academic cytometry facility and continues to design and build next generation cell sorters, commercial flow cytometers and confocal microscopes.

Bill Ihrie

Bill Ihrie, Software Executive, Former Senior VP and CTO, Intuit Inc.

Bill Ihrie is a seasoned executive with 40 years of experience in the software industry. Most recently he was a senior vice president at Intuit for more than eight years—six as CTO, and two running product development for the small business division, which generates over half of the company’s revenue. Prior to Intuit, Bill was senior vice president at ADP for ten years, running product development and business strategy for the claims solutions and dealer services divisions. Previously Bill worked at Security Pacific Bank, Computer Usage Company, and Bell Labs. Bill earned B.S. degrees in Mathematics and Management from MIT and an M.A. in Computer Science from the University of California, Berkeley.

Garry Nolan

Garry Nolan, Ph.D., Director, NHLBI Proteomics Center for Systems Immunology and Professor, Stanford University

Dr. Garry Nolan is the director of the NHLBI Proteomics Center for Systems Immunology and the Rachford and Carlota A. Harris Professor in the Department of Microbiology and Immunology at Stanford University School of Medicine. He has published more than 160 research articles, is the holder of 17 U.S. patents, and has been honored as one of the top 25 inventors at Stanford University. Dr. Nolan was the founder of Rigel Inc. (NASDAQ: RIGL) and Nodality, Inc., a diagnostics development company; he serves on the boards of directors of several companies. His areas of research include hematopoiesis, cancer and leukemia, autoimmunity and inflammation, and computational approaches for network and systems immunology. Dr. Nolan’s efforts are to enable a deeper understanding not only of normal immune function, but also of detailed substructures of leukemias and solid cancers—which will enable wholly new understandings that will enable better management of disease and clinical outcomes. Dr. Nolan received his Ph.D. in Genetics at Stanford University under the mentorship of the Herzenbergs, where he worked on the cloning of CD8 and development of the first single-cell reporter gene assays. Dr. Nolan did his postdoctoral work in the laboratory of Nobelist David Baltimore at MIT. While working in the Baltimore lab, he co­-developed retroviral systems that are now a mainstay of retroviral and lentiviral production in research and gene therapy.